AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28249684 — intervention group
Group type: EXPERIMENTAL
Intervention: ETT without MR (group 2)
Number of subjects: 78
Study 28249684 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA with subparalytic dose of MR (group 3)
Number of subjects: 78
Study 28249684 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA without MR (group 4)
Number of subjects: 78
Study 25403334 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhodiola crenulata 500 mg daily for 12 weeks
Number of subjects: 38
Study 25403334 — intervention group
Group type: COMPARATOR
Intervention: Placebo (starch/phosphate buffered saline) daily for 12 weeks
Number of subjects: 38
Study 23715475 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention for 6 months in addition to hospital routine care
Number of subjects: 75
Study 23715475 — intervention group
Group type: COMPARATOR
Intervention: Hospital routine care only
Number of subjects: 75
Study 21241369 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT) measurements of hair shafts from alopecic area
Number of subjects: 9
Study 21241369 — intervention group
Group type: COMPARATOR
Intervention: Optical coherence tomography (OCT) measurements of hair shafts from unaffected area
Number of subjects: 9
Study 18081753 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone + desloratadine (10 mg daily)
Number of subjects: 65
Study 18081753 — intervention group
Group type: COMPARATOR
Intervention: Desloratadine (10 mg daily)
Number of subjects: 65
Study 16987381 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy (CRT)
Number of subjects: 15
Study 16987381 — intervention group
Group type: COMPARATOR
Intervention: Conventional CRT indication (control group)
Number of subjects: 15
Study 12589118 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS)
Number of subjects: 104
Study 12589118 — intervention group
Group type: COMPARATOR
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 104
Study 10553740 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day)
Number of subjects: 131
Study 10553740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 8920847 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic estimates
Number of subjects: 72
Study 8920847 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual estimates
Number of subjects: 72
Study 8920847 — intervention group
Group type: COMPARATOR
Intervention: Knowledge of estimate type
Number of subjects: 72
Study 1862893 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.125% with fentanyl 0.0002%
Number of subjects: 56
Study 1862893 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.062% with fentanyl 0.0002%
Number of subjects: 56
Study 1862893 — intervention group
Group type: EXPERIMENTAL
Intervention: bupivacaine 0.031% with fentanyl 0.0002%
Number of subjects: 56
Study 1862893 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine 0.5% 8 ml initial dose with fentanyl 0.0002%
Number of subjects: 56
Study 6641089 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose perhexiline during exercise training
Number of subjects: 22
Study 6641089 — intervention group
Group type: COMPARATOR
Intervention: Placebo during exercise training
Number of subjects: 22
Study 6641089 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose perhexiline
Number of subjects: 22
Study 31916303 — intervention group
Group type: EXPERIMENTAL
Intervention: NRT sampling plus standard care (SC)
Number of subjects: 1245
Study 31916303 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 1245
Study 28914700 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of IV ketorolac
Number of subjects: 40
Study 28914700 — intervention group
Group type: COMPARATOR
Intervention: IV saline placebo
Number of subjects: 40
Study 28185214 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein apheresis (LA), regular LA treatment over 5 years
Number of subjects: 170
Study 25275609 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0
Study 25275609 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 0
Study 23848384 — intervention group
Group type: EXPERIMENTAL
Intervention: Competition (Yes)
Number of subjects: 147
Study 23848384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intergroup competition (Yes)
Number of subjects: 147
Study 23848384 — intervention group
Group type: COMPARATOR
Intervention: Non-competitive work (No)
Number of subjects: 147
Study 20853269 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg intravitreal bevacizumab at the end of surgery
Number of subjects: 61
Study 20853269 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification with intraocular lens implantation alone (control group)
Number of subjects: 61
Study 18195176 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa (N=162), subcutaneously every 2 weeks for 1 year
Number of subjects: 319
Study 18195176 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=157)
Number of subjects: 319
Study 18195176 — intervention group
Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa
Number of subjects: 319
Study 18195176 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa and Placebo
Number of subjects: 319
Study 16368284 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OAC) plus antiplatelet therapy
Number of subjects: 4889
Study 16368284 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulants (OAC)
Number of subjects: 4889
Study 16368284 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 4889
Study 16368284 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 4889
Study 12718496 — intervention group
Group type: EXPERIMENTAL
Intervention: Software program stimulating to take extra breaks
Number of subjects: 268
Study 12718496 — intervention group
Group type: EXPERIMENTAL
Intervention: Software program stimulating to perform exercises during extra breaks
Number of subjects: 268
Study 12718496 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 268
Study 12718496 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention groups (both types)
Number of subjects: 268
Study 12718496 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 268
Study 10704621 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (0.01‐10 microM)
Number of subjects: 0
Study 10704621 — intervention group
Group type: COMPARATOR
Intervention: Medium (Control)
Number of subjects: 0
Study 9092958 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM) at target daily dosages of up to 9 mg/kg/day
Number of subjects: 18
Study 9092958 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive TPM therapy
Number of subjects: 18
Study 9092958 — intervention group
Group type: EXPERIMENTAL
Intervention: TPM monotherapy substitution
Number of subjects: 18
Study 8403580 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA), 7 injections over 6 weeks
Number of subjects: 57
Study 8403580 — intervention group
Group type: COMPARATOR
Intervention: Mucopolysaccharide polysulfuric acid ester (MPA), 13 injections over 6 weeks
Number of subjects: 57
Study 3782677 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine with low sulfur dioxide (SO2) and high amine
Number of subjects: 18
Study 3782677 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine with high sulfur dioxide (SO2) and high amine
Number of subjects: 18
Study 3782677 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine with low sulfur dioxide (SO2) and low amine
Number of subjects: 18
Study 31674564 — intervention group
Group type: EXPERIMENTAL
Intervention: CS (Calibrate, and then Stitch) algorithm
Number of subjects: 0
Study 31674564 — intervention group
Group type: EXPERIMENTAL
Intervention: SC (Stitch, and then Calibrate) algorithm
Number of subjects: 0
Study 31674564 — intervention group
Group type: EXPERIMENTAL
Intervention: 2D scans with step randomization
Number of subjects: 0
Study 31674564 — intervention group
Group type: EXPERIMENTAL
Intervention: Regularization on low-order terms
Number of subjects: 0
Study 31674564 — intervention group
Group type: EXPERIMENTAL
Intervention: Numerical simulations and experiments
Number of subjects: 0
Study 29975728 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-reduced infant formula (1.89 g protein/100 kcal) with alpha-lactalbumin enriched whey and long-chain polyunsaturated fatty acids (LC-PUFA)
Number of subjects: 259
Study 29975728 — intervention group
Group type: COMPARATOR
Intervention: Standard formula (2.2 g protein/100 kcal) without LC-PUFA
Number of subjects: 259
Study 29975728 — intervention group
Group type: COMPARATOR
Intervention: Non-randomized breastfed infants (reference group)
Number of subjects: 259
Study 29975728 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolites measured at 4 months (Asn, Lys, Met, Phe, Trp, Tyr)
Number of subjects: 259
Study 29975728 — intervention group
Group type: EXPERIMENTAL
Intervention: Measured metabolites
Number of subjects: 259
Study 29975728 — intervention group
Group type: EXPERIMENTAL
Intervention: Early growth patterns
Number of subjects: 259
Study 27957486 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA (Mineral Trioxide Aggregate)
Number of subjects: 50
Study 27957486 — intervention group
Group type: COMPARATOR
Intervention: IRM (Intermediate Restorative Material)
Number of subjects: 50
Study 24615094 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (target plasma concentration 3 ng/mL)
Number of subjects: 60
Study 24615094 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (target plasma concentration 2 μg/mL)
Number of subjects: 60
Study 24615094 — intervention group
Group type: COMPARATOR
Intervention: Control group (waiting for extubation)
Number of subjects: 60
Study 22990628 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity aerobic exercise (treadmill running)
Number of subjects: 0
Study 22990628 — intervention group
Group type: COMPARATOR
Intervention: Very high intensity aerobic exercise (treadmill running)
Number of subjects: 0
Study 22990628 — intervention group
Group type: COMPARATOR
Intervention: Very low intensity aerobic exercise (treadmill running)
Number of subjects: 0
Study 20635523 — intervention group
Group type: EXPERIMENTAL
Intervention: Music only
Number of subjects: 32
Study 20635523 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation only (PMR)
Number of subjects: 32
Study 20635523 — intervention group
Group type: EXPERIMENTAL
Intervention: Music combined with progressive muscle relaxation
Number of subjects: 32
Study 20635523 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 18398095 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ICE chemotherapy (ifosfamide, carboplatin, etoposide) with PBPC support
Number of subjects: 140
Study 18398095 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose ICE chemotherapy (ifosfamide, carboplatin, etoposide)
Number of subjects: 140
Study 18398095 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose ICE chemotherapy
Number of subjects: 140
Study 18398095 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose ICE chemotherapy
Number of subjects: 140
Study 16872244 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day
Number of subjects: 72
Study 16872244 — intervention group
Group type: EXPERIMENTAL
Intervention: simvastatin 40 mg/day
Number of subjects: 72
Study 16872244 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe 10 mg/day plus simvastatin 40 mg/day
Number of subjects: 72
Study 14635608 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretics (in males)
Number of subjects: 70
Study 14635608 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockaders (in women)
Number of subjects: 70
Study 14635608 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockaders alpha (in women)
Number of subjects: 70
Study 14635608 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive treatment (phase 1)
Number of subjects: 70
Study 11014911 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorzoin varnish
Number of subjects: 1240
Study 11014911 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with protocol (regular visits with dental auxiliaries)
Number of subjects: 1240
Study 11014911 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 1240
Study 11014911 — intervention group
Group type: COMPARATOR
Intervention: Control group (observational)
Number of subjects: 1240
Study 8615470 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative combination treatment (radiation, intraluminal hyperthermia, and 5-fluorouracil suppositories)
Number of subjects: 35
Study 8615470 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery after preoperative combination treatment
Number of subjects: 35
Study 8615470 — intervention group
Group type: COMPARATOR
Intervention: Surgery without pretreatment (control group)
Number of subjects: 35
Study 1731577 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm bath (41 degrees C for 1/2 h, 2 1/2 h before sleep study)
Number of subjects: 7
Study 1731577 — intervention group
Group type: COMPARATOR
Intervention: Control (no warm bath)
Number of subjects: 7
Study 3805328 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment (0.8 mEq/liter for 1 week)
Number of subjects: 12
Study 3805328 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium treatment
Number of subjects: 12
Study 29971998 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Xialiao (BL 34) and Changqiang (GV 1), once a day.
Number of subjects: 90
Study 29971998 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular point sticking therapy at bilateral shenmen (TF4), pizhixia (AT4), jiaogan (AH6a) and gangmen (HX5), pressing 3-6 times every day, once 3-5 min.
Number of subjects: 90
Study 29971998 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (EA + auricular point sticking therapy).
Number of subjects: 90
Study 27801598 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric-only (ECC)
Number of subjects: 34
Study 27801598 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric-only (CONC)
Number of subjects: 34
Study 27801598 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional concentric-eccentric (TRAD)
Number of subjects: 34
Study 27801598 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 25339836 — intervention group
Group type: EXPERIMENTAL
Intervention: Split-dose of 2-litre PEG-ELS
Number of subjects: 295
Study 25339836 — intervention group
Group type: COMPARATOR
Intervention: Whole-dose of 2-litre PEG-ELS
Number of subjects: 295
Study 20479755 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol challenge in carriers of the minor 118G allele
Number of subjects: 0
Study 20479755 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge in carriers of the minor 118G allele
Number of subjects: 0
Study 20479755 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol challenge in h/mOPRM1‐118GG mice
Number of subjects: 0
Study 20479755 — intervention group
Group type: COMPARATOR
Intervention: Alcohol challenge in h/mOPRM1‐118AA mice
Number of subjects: 0
Study 16275527 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress echocardiography
Number of subjects: 487
Study 12140209 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic (150 mOsm/l) 0.4% hyaluronate eye drops
Number of subjects: 40
Study 12140209 — intervention group
Group type: COMPARATOR
Intervention: Isotonic 0.4% hyaluronate eye drops
Number of subjects: 40
Study 9656236 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐2, LAK adoptive immunotherapy
Number of subjects: 0
Study 9656236 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication
Number of subjects: 396
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication with antibiotics
Number of subjects: 396
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication with vitamins
Number of subjects: 396
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-medication for asthenia
Number of subjects: 396
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous medical prescription
Number of subjects: 396
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Common pharmacological groups
Number of subjects: 396
Study 7654922 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory conditions
Number of subjects: 396
Study 2647677 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling
Number of subjects: 60
Study 2647677 — intervention group
Group type: EXPERIMENTAL
Intervention: Modeling plus coping skills
Number of subjects: 60
Study 2647677 — intervention group
Group type: EXPERIMENTAL
Intervention: Any preparatory treatment
Number of subjects: 60
Study 2647677 — intervention group
Group type: COMPARATOR
Intervention: Attention placebo control
Number of subjects: 60
Study 52766 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate/low-fat diet
Number of subjects: 8
Study 52766 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate/high-fat diet
Number of subjects: 8
Study 52766 — intervention group
Group type: COMPARATOR
Intervention: Normal balanced diet
Number of subjects: 8
Study 12138261 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucocytapheresis (LAP group)
Number of subjects: 32
Study 12138261 — intervention group
Group type: COMPARATOR
Intervention: Steroid pulse therapy (steroid pulse group)
Number of subjects: 32
Study 31424972 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored DAA treatment based on baseline resistance findings, including prolonged treatment duration of NS5A-inhibitor and sofosbuvir (SOF) and/or addition of ribavirin (RBV) for patients with baseline Y93H.
Number of subjects: 208
Study 31424972 — intervention group
Group type: COMPARATOR
Intervention: Standard DAA treatment for patients without baseline Y93H and all patients in the control group.
Number of subjects: 208
Study 31424972 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized treatment for patients with baseline Y93H in the intervention group.
Number of subjects: 208
Study 31424972 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for patients with baseline Y93H in the control group.
Number of subjects: 208
Study 29615318 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (50,000 IU every 25 days for 3 months)
Number of subjects: 66
Study 29615318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 26878247 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-focus NBI (DF-NBI)
Number of subjects: 93
Study 26878247 — intervention group
Group type: COMPARATOR
Intervention: Conventional magnification NBI (CM-NBI)
Number of subjects: 93
Study 26878247 — intervention group
Group type: COMPARATOR
Intervention: Conventional magnification endoscope
Number of subjects: 93
Study 26878247 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-focus endoscope
Number of subjects: 93
Study 24707819 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal presence during lullaby music exposure
Number of subjects: 22
Study 24707819 — intervention group
Group type: COMPARATOR
Intervention: Ambient sound
Number of subjects: 22
Study 22214529 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehearsing enjoyable aspects of food immediately after eating
Number of subjects: 0
Study 22214529 — intervention group
Group type: COMPARATOR
Intervention: Control group (no rehearsal of enjoyment)
Number of subjects: 0
Study 20432339 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI examination at 1.5 T
Number of subjects: 25
Study 20432339 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI examination at 7 T
Number of subjects: 25
Study 18346959 — intervention group
Group type: EXPERIMENTAL
Intervention: Off pump coronary artery bypass (OPCAB)
Number of subjects: 0
Study 18346959 — intervention group
Group type: COMPARATOR
Intervention: On pump CABG (coronary artery bypass grafting)
Number of subjects: 0
Study 15731561 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal balloon endometrial ablation
Number of subjects: 34
Study 15731561 — intervention group
Group type: COMPARATOR
Intervention: Progestin therapy
Number of subjects: 34
Study 15731561 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 34
Study 12403606 — intervention group
Group type: EXPERIMENTAL
Intervention: Syllabic compression (fast time constant)
Number of subjects: 38
Study 12403606 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency emphasis (SPIN setting)
Number of subjects: 38
Study 12403606 — intervention group
Group type: COMPARATOR
Intervention: Comfort-oriented pre-set program (AUTO)
Number of subjects: 38
Study 12403606 — intervention group
Group type: COMPARATOR
Intervention: Slow compression (AVC)
Number of subjects: 38
Study 12403606 — intervention group
Group type: COMPARATOR
Intervention: Intermediate compression (NORMAL)
Number of subjects: 38
Study 9793946 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrobulbar anesthesia (4 cc of a 50:50 mixture of 2% xylocaine and 0.75% bupivacaine with 150 units of hyaluronidase)
Number of subjects: 59
Study 9793946 — intervention group
Group type: COMPARATOR
Intervention: Peribulbar anesthesia (6 cc of a 50:50 mixture of 2% xylocaine and 0.75% bupivacaine with 150 units of hyaluronidase)
Number of subjects: 59
Study 7659384 — intervention group
Group type: EXPERIMENTAL
Intervention: 111In-HIG
Number of subjects: 57
Study 7659384 — intervention group
Group type: COMPARATOR
Intervention: Chest radiology
Number of subjects: 57
Study 2565416 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg bd tazifylline
Number of subjects: 11
Study 2565416 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 1052162 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (200 mg intravenous infusion)
Number of subjects: 20
Study 1052162 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (10 ml)
Number of subjects: 20
Study 31669091 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% iodine solution (group A)
Number of subjects: 77
Study 31669091 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% iodine solution (group B)
Number of subjects: 77
Study 31419427 — intervention group
Group type: EXPERIMENTAL
Intervention: Habitual physical exercise
Number of subjects: 0